Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.47 USD
Change Today +0.02 / 0.82%
Volume 282.7K
CYTR On Other Exchanges
As of 8:10 PM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Daniel Levitt M.D., Ph.D.

Chief Medical Officer and Executive Vice President,CytRx Corporation
AgeTotal Calculated CompensationThis person is connected to 5 board members in 1 different organizations across 10 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Daniel J. Levitt, also known as Dan, M.D., Ph.D., has been the Chief Medical Officer of CytRx Corporation since October 2009 and as its Executive Vice President since January 2013. Prior to CytRx, Dr. Levitt served as an Executive Vice President of Research and Development at Cerimon Pharmaceuticals, Inc. since January 8, 2007, where he implemented three Phase III pivotal trials. He directed Cerimon's product development activities and manage Cerimon's clinical programs ...

Read Full Background

Corporate Headquarters*

11726 San Vicente Boulevard
Los Angeles, California 90049

United States

Phone: 310-826-5648
Fax: 310-826-6139

Board Members Memberships*

Independent Director, Member of Compensation Committee and Member of Nominating & Corporate Governance Committee


Brandeis University
Loyola University of Chicago
Loyola University of Chicago
Post-Doctoral Training
Yale University School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$825,000

Stock Options*

Exercisable Options436,511
Unexercisable Options733,333
Total Number of Options1,169,844

Total Compensation*

Total Annual Cash Compensation$825,000
Total Short Term Compensation$825,000
Total Calculated Compensation$1,427,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTR:US $2.47 USD +0.02


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTRX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at